Cargando…
2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
BACKGROUND: In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-assoc...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254123/ http://dx.doi.org/10.1093/ofid/ofy210.1747 |
_version_ | 1783373651689603072 |
---|---|
author | Kwon, Ki Tae Lee, Won Kee Yu, Mi Hyae Park, Hyun Ju Lee, Kyeong Hee Chae, Hyun Ju |
author_facet | Kwon, Ki Tae Lee, Won Kee Yu, Mi Hyae Park, Hyun Ju Lee, Kyeong Hee Chae, Hyun Ju |
author_sort | Kwon, Ki Tae |
collection | PubMed |
description | BACKGROUND: In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-associated bloodstream infections (CLABSI). METHODS: A before-and-after study between pre-intervention (January 2016 to February 2017) and intervention (March 2017 to December 2017) periods was performed in three intensive care units (ICU) at Daegu Fatima Hospital (a 750-bed, secondary care hospital in Daegu, Republic of Korea). The number of dedicated IC nurses increased from 2 to 5 in September 2016 and a first dedicated IC doctor was allocated in March 2017 according to the IC cost reimbursement policy. The enhanced IC team visited ICUs daily and monitor and educate the implementation of CLABSI prevention bundles. The trends between pre-intervention and intervention periods were analyzed by segmented autoregression analysis of an interrupted time series. RESULTS: The average CLABSI rates and total central-line days in the pre-intervention and intervention periods were 3.41 and 2.34 per 1,000 catheter-days; 7,326 and 5,978 days, respectively. Autoregressive analysis revealed that the CLABSI rates per 1,000 catheter days per month in the pre-intervention and intervention periods were -0.256 (95% confidence interval (CI), −0.593, 0.081; P = 0.148) and −0.602 (95% CI, −0.935, −0.268; P = 0.008). The rates of compliance with maximal barrier precaution significantly improved from pre-intervention (55.1%) to intervention (89.4%) period (chi-square test, P < 0.001). The rates of compliance with maintenance bundles also significantly improved from pre-intervention (48.4%) to intervention (69.7%) period (chi-square test, P < 0.001) CONCLUSION: The reimbursement policy for IC cost accelerates the decline in CLABSI rates by increasing the number of IC professionals and improving monitoring, education and implementation of CLABSI prevention bundles. DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6254123 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-62541232018-11-28 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections Kwon, Ki Tae Lee, Won Kee Yu, Mi Hyae Park, Hyun Ju Lee, Kyeong Hee Chae, Hyun Ju Open Forum Infect Dis Abstracts BACKGROUND: In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-associated bloodstream infections (CLABSI). METHODS: A before-and-after study between pre-intervention (January 2016 to February 2017) and intervention (March 2017 to December 2017) periods was performed in three intensive care units (ICU) at Daegu Fatima Hospital (a 750-bed, secondary care hospital in Daegu, Republic of Korea). The number of dedicated IC nurses increased from 2 to 5 in September 2016 and a first dedicated IC doctor was allocated in March 2017 according to the IC cost reimbursement policy. The enhanced IC team visited ICUs daily and monitor and educate the implementation of CLABSI prevention bundles. The trends between pre-intervention and intervention periods were analyzed by segmented autoregression analysis of an interrupted time series. RESULTS: The average CLABSI rates and total central-line days in the pre-intervention and intervention periods were 3.41 and 2.34 per 1,000 catheter-days; 7,326 and 5,978 days, respectively. Autoregressive analysis revealed that the CLABSI rates per 1,000 catheter days per month in the pre-intervention and intervention periods were -0.256 (95% confidence interval (CI), −0.593, 0.081; P = 0.148) and −0.602 (95% CI, −0.935, −0.268; P = 0.008). The rates of compliance with maximal barrier precaution significantly improved from pre-intervention (55.1%) to intervention (89.4%) period (chi-square test, P < 0.001). The rates of compliance with maintenance bundles also significantly improved from pre-intervention (48.4%) to intervention (69.7%) period (chi-square test, P < 0.001) CONCLUSION: The reimbursement policy for IC cost accelerates the decline in CLABSI rates by increasing the number of IC professionals and improving monitoring, education and implementation of CLABSI prevention bundles. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254123/ http://dx.doi.org/10.1093/ofid/ofy210.1747 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Kwon, Ki Tae Lee, Won Kee Yu, Mi Hyae Park, Hyun Ju Lee, Kyeong Hee Chae, Hyun Ju 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections |
title | 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections |
title_full | 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections |
title_fullStr | 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections |
title_full_unstemmed | 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections |
title_short | 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections |
title_sort | 2091. the impact of infection control cost reimbursement policy on trends in central line-associated bloodstream infections |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254123/ http://dx.doi.org/10.1093/ofid/ofy210.1747 |
work_keys_str_mv | AT kwonkitae 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections AT leewonkee 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections AT yumihyae 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections AT parkhyunju 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections AT leekyeonghee 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections AT chaehyunju 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections |